Bryan C. Hanson is the President and CEO of Zimmer Biomet Holdings, a major player in the medical device industry. He has been leading the company since December 2017. His background includes key roles at Medtronic and Covidien, where he...

Bryan C. Hanson is the President and CEO of Zimmer Biomet Holdings, a major player in the medical device industry. He has been leading the company since December 2017. His background includes key roles at Medtronic and Covidien, where he gained a lot of experience in managing and growing businesses in the healthcare sector. Under his leadership, Zimmer Biomet has focused on innovation and addressing challenges in patient care. Interestingly, during the COVID-19 pandemic, he even decided to forgo his entire salary to support the company. In 2023, his total compensation was reported at $4.2 million, demonstrating his financial commitment amid changes. Before his time as CEO, he made significant contributions to different areas, emphasizing his ability to adapt and evolve within highly regulated environments. Hanson holds a degree in Finance and has completed executive programs at the Kellogg School of Management and Harvard, which shows his dedication to continuous learning. He is also involved with Americares, an organization focused on global health and emergency response, underlining his commitment to improving lives beyond just corporate success.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Zimmer Biomet Holdings CEOs

Z

Bryan C. Hanson

CEO of Zimmer Biomet Holdings

Education

N/A

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

January 1, 1967 - 58 years ago

CEO of Zimmer Biomet Holdings for

7 years 3 months (Dec 2017 - Present)

Previous Experience

Executive Vice President and President, Minimally Invasive Therapies Group of Medtronic

Rivals

Competitors/colleagues of Bryan C. Hanson

P

Adam Elsesser

CEO of Penumbra

2023 Compensation

Stock

$0.00

Salary

$600.00K

Bonus

$0.00

Other

$1.62K

Total Holdings

$244.34M

S

Kevin A. Lobo

CEO of Stryker

2023 Compensation

Stock

$0.00

Salary

$1.39M

Bonus

$3.78M

Other

$532.65K

Total Holdings

$54.60M

Holdings

See how much did Bryan C. Hanson make over time.

Bryan C. Hanson has been steadily involved in Zimmer Biomet's stock over the years. In 2019, his holdings peaked at around $10.46 million, signifying a strong investment in the company. However, there has been a gradual decline in his stock...

Bryan C. Hanson has been steadily involved in Zimmer Biomet's stock over the years. In 2019, his holdings peaked at around $10.46 million, signifying a strong investment in the company. However, there has been a gradual decline in his stock value leading up to 2023, where his insider trading activity showed values around $7 million. This represents a significant drop from his earlier peaks. The fluctuations show the ups and downs of being in such a volatile market, especially after the challenges brought on by the pandemic. His commitment can be seen in these numbers, as he maintains a keen interest in the company’s performance.

Total Stock Sold

$9.96M

MDT

$9.96M

120,272 MDT shares

What if they kept their stock?

If Bryan C. Hanson didn't sell their stock, today they would have:
Extra MDT120,272 shares worth $12.15M.
This is 21.94% and $2.19M more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Bryan C. Hanson.

ZBH

$113.00K

ZBH at $113.00/share

May 13, 2020

Purchase

ZBH

$249.96K

ZBH at $119.03/share

Feb 7, 2019

Purchase

ZBH

$50.44K

ZBH at $123.03/share

Aug 31, 2018

Purchase

ZBH

$3.00M

ZBH at $119.65/share

Feb 15, 2018

Purchase

MDT

$1.33M

MDT at $82.82/share

Dec 15, 2017

Sale

MDT

$1.26M

MDT at $79.02/share

Nov 16, 2017

Sale

MDT

$1.25M

MDT at $78.03/share

Oct 16, 2017

Sale

MDT

$1.22M

MDT at $83.97/share

Jul 31, 2017

Received

MDT

$1.06M

MDT at $88.57/share

Jul 17, 2017

Sale

MDT

$1.31M

MDT at $87.00/share

Aug 29, 2016

Sale

Compensation History

See how much did Bryan C. Hanson make over time.

In 2023, Bryan C. Hanson received a total compensation package of approximately $4.2 million. This included a salary of about $1.26 million and a significant portion coming from his deferred compensation plan. Notably, he had no bonuses, stock grants, or options due to his separation from the company. This contrasts sharply with his 2022 compensation of over $16 million, which featured performance-based incentives. Over the years, Hanson's compensation strategy has focused on aligning his pay with the company's overall performance and shareholder interests, emphasizing the importance of achieving solid financial results.

Year

2023

Total Compensation

$4.17M

Salary

$1.26M

Board Justification

The compensation philosophy emphasizes performance-based compensation that aligns executive pay with company performance and shareholder interests, focusing on long-term value creation.

Bonus

$0.00

Board Justification

Mr. Hanson forfeited his opportunity under the annual cash incentive plan upon his separation from the company, and therefore the below discussion does not include information for Mr. Hanson.

Other

$2.91M

Board Justification

This amount represents the DCP (Deferred Compensation Plan) balance as of August 31, 2023, when Mr. Hanson separated from the company.

Restricted Stock

$0.00(0 RSU)

Board Justification

Mr. Hanson forfeited his outstanding unvested PRSU, RSU and stock option awards in connection with his separation in August 2023.

Performance Metrics

The performance metrics for the CEO's compensation included company financial performance measures such as constant currency revenue, adjusted operating profit, and free cash flow.

Other Zimmer Biomet Holdings CEOs

Here are other CEOs of Zimmer Biomet Holdings

Daniel P. Florin

Ex-CEO of Zimmer Biomet Holdings

July 2017 - December 2017